abagovomab 50
abciximab 44
abituzumab 35
abrilumab 26
actoxumab 31
adalimumab 21
aducanumab 20
afasevikumab 19
alacizumab_pegol 14
alemtuzumab 41
alirocumab 20
amatuximab 54
andecaliximab 33
anifrolumab 32
anrukinzumab 21
aprutumab 23
aprutumab_ixadotin 23
arcitumomab 25
ascrinvacumab 25
atezolizumab 16
atinumab 21
avelumab 19
basiliximab 53
bavituximab 47
begelomab 45
benralizumab 35
bevacizumab_beta 25
bezlotoxumab 31
bimagrumab 26
bleselumab 38
blinatumomab 51
blosozumab 43
bococizumab 31
brazikumab 24
brentuximab_vedotin 46
briakinumab 25
brodalumab 31
brolucizumab 33
brontictuzumab 37
burosumab 40
cabiralizumab 41
camrelizumab 17
canakinumab 29
cantuzumab_ravtansin 56
carlumab 28
carotuximab 22
cergutuzumab_amunaleukin2 36
cergutuzumab_amunaleukin 36
certolizumab_pegol 29
cetiximab 45
citatuzumab_bogatox 35
cixutumumab 48
clivatuzumab_tetraxetan 35
codrituzumab 29
conatumumab 26
concizumab 25
crenezumab 23
crizanlizumab 36
crotedumab 29
dacetuzumab 24
daclizumab 29
dalotuzumab 40
dapirolizumab_pegol 30
daratumumab 16
dectrekumab 15
demcizumab 41
denosumab 11
depatuxizumab 35
depatuxizumab_mafodotin 35
dezamizumab 36
dinutuximab 45
diridavumab 35
domagrozumab 18
drozitumab 22
duligotuzumab 22
durvalumab 17
dusigitumab 39
efalizumab 40
efungumab 31
eldelumab 20
elezanumab 38
elgemtumab 15
elotuzumab 22
emactuzumab 36
emapalumab 29
emibetuzumab 34
enavatuzumab 29
enfortumab_vedotin 19
enoblituzumab 24
enokizumab 36
enoticumab 27
ensituximab 43
eptinezumab 20
erenumab 32
etaracizumab 17
etrolizumab 26
evinacumab 26
evolocumab 36
farletuzumab 8
fasinumab 34
fezakinumab 39
fibatuzumab 31
ficlatuzumab 37
firivumab 36
flanvotumab 28
fletikumab 44
foralumab 19
foravirumab 22
fremanezumab 32
fresolimumab 26
fulranumab 27
futuximab 39
galcanezumab 26
ganitumab 35
gantenerumab 17
gemetuzumab 37
gemtuzumab2 39
gemtuzumab 39
gevokizumab 35
girentuximab 36
glembatumumab 36
glembatumumab_vedotin 36
guselkumab 37
ibalizumab 37
ibritumomab 48
icrucumab 16
idarucizumab 44
ifabotuzumab 31
imalumab 18
imgatuzumab 37
inclacumab 26
indatuximab_ravtansin 41
indusatumab 31
inebilizumab 36
intetumumab 20
iodine_girentuximab 34
ipilimumab 5
iratumumab 27
isatuximab 45
itolizumab 33
ixekizumab 36
labetuzumab_govitecan 29
lambrolizumab 43
lampalizumab 30
lanadelumab 24
landogrozumab 24
laprituximab 39
lebrikizumab 40
lendalizumab 39
lenzilumab 33
lifastuzumab_vedotin 26
ligelizumab 35
lilotomab 41
lirilumab 38
lodelcizumab 32
lokivetmab 28
lorvotuzumab_mertansin 24
lucatumumab 34
lumretuzumab 32
lupartumab 22
lutikizumab 19
margetuximab 42
milatuzumab 36
mirvetuximab 50
mirvetuximab_soravtansin 50
modotuximab 59
mogamulizumab 27
monalizumab 37
motavizumab 38
moxetumomab_pasudotox 26
namilumab 39
naratuximab 50
naratuximab_emtansin 50
narnatumab 22
navicixizumab2 32
navicixizumab 42
navivumab 48
necitumumab 29
nemolizumab 41
nesvacumab 16
nivolumab 22
obiltoxaximab 28
obinutuzumab 40
ocaratuzumab 35
ofatumumab 21
olaratumab 40
olokizumab 29
omalizumab 26
onartuzumab 28
ontuxizumab 34
opicinumab 17
orticumab 16
otelixizumab 41
oxelumab 14
ozanezumab 35
pamrevlumab 17
panobacumab 23
parsatuzumab 34
pasotuxizumab 19
pateclizumab 23
patritumab 35
pembrolizumab 43
perakizumab 26
pidilizumab 21
pinatuzumab_vedotin 21
plozalizumab 28
pogalizumab 38
polatuzumab_vedotin 25
ponezumab 46
prezalumab 19
pritoxaximab 51
quilizumab 20
racotumomab 44
radretumab 19
ralpancizumab 36
ramucirumab 22
ranevetmab 36
ranibizumab 24
refanezumab 28
remtolumab 22
rilotumumab 33
rinucumab 30
risankizumab 41
rituximab 37
rivabazumab 27
robatumumab 22
roledumab 32
romosozumab 38
rontalizumab 29
rosmantuzumab 40
rozanolixizumab 24
sacituzumab 34
sacituzumab_govitecan 34
samalizumab 42
sapelizumab 38
sarilumab 24
secukinumab 24
seribantumab 22
setoxaximab 46
sifalimumab 23
siltuximab 29
simtuzumab 40
sirukumab 16
solanezumab 30
solitomab 38
stamulumab 38
suptavumab 32
suvizumab 22
tabalumab 35
tadocizumab 29
tamtuvetmab 35
tanezumab 34
tarextumab 15
tavolixizumab 30
telisotuzumab 43
teplizumab 26
tesidolumab 36
tezepelumab 30
tigatuzumab 16
tildrakizumab 37
timolumab 20
tisotumab 19
tosatoxumab 43
tositumomab 45
tralokinumab 44
trastuzumab 28
tregalizumab 25
trevogrumab 20
ublituximab 41
urelumab 33
ustekinumab 37
utomilumab 36
vadastuximab 43
vadastuximab_talirin 43
vandortuzumab_vedotin 25
vantictumab 29
vanucizumab2 25
vanucizumab 53
varlilumab 22
vatelizumab 42
vedolizumab 41
veltuzumab 29
vesencumab 15
vorsetuzumab 38
vorsetuzumab_mafodotin 38
vunakizumab 47
xentuzumab 24
zatuximab 59
